Capacity, Risk, And The Role Of Digital Innovation
This portion of Driving Efficiency, Reducing Costs in Multi-Modal CGT Manufacturing featuring expert panelists Steve Awad, Principal Director, Supply Chain & Industry X — Life Sciences, Accenture, and Michael Blackton, MBA, VP, Manufacturing and Supply at Ocugen focused on how developers can assess whether a CDMO is truly equipped to support multimodal programs without introducing capacity bottlenecks, quality drift, or compliance risk. Our experts emphasized that credible CDMOs demonstrate both process maturity through documented, consistently followed planning practices and digital maturity with robust capacity models and simulation tools rather than ad hoc spreadsheets. When managing multiple modalities under one roof, red flags include inconsistent application of quality systems across clients and overreliance on human vigilance instead of engineered controls, such as physical segregation, error-proofing, and digital traceability.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.